U.S. federal trademark · Serial No. 87614253 · Reg. No. 5609691
drug development services; development of pharmaceutical preparations for the targeted treatment of diseased sites related to cancer, central nervous system and neurological degenerative diseases, neurodevelopmental and psychiatric disorders, and pharmaceutical preparations for the treatment of cancer, central nervous system and neurological degenerative diseases, neurodevelopmental and psychiatric disorders, for use as drug delivery vehicles that selectively targets drugs to diseased sites related to cancer, central nervous system and neurological degenerative diseases, neurodevelopmental and psychiatric disorders, with minimal side effects
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.